- A new study looks at potential coronavirus treatments that could save people from serious COVID-19 complications and even death.
- Researchers at the University of Maryland School of Medicine have found that a common home remedy, aspirin, when used under certain circumstances, resulted in fewer hospital admissions, as well as fewer coronavirus patients admitted to the ICU or having to go on a ventilator.
- The news is coming because the U.S. The daily coronavirus keeps setting new records for case number.
Most of you may have already noticed, but the suggestions contained in the news headlines related to coronavirus seem more terrifying in the coming days and weeks than we are in the store. Health experts are predicting that the worst days of the Kovid-1 epidemic are ahead of us – and, in fact, the worst epidemic could come soon.
Along these lines, the U.S. on Thursday set another record for the number of new coronavirus cases nationwide, reaching 77,000 – a height not seen since July. U.S. Overall the case since the outbreak began. Millions are closing in, according to Johns Hopkins University, and there have been more than 44,000 deaths. In those maps, meanwhile, comes a landmark study that provides some good news regarding the epidemic – and suggests you already have a potential coronavirus treatment at home.
It is not in the treatment of therapeutic structural modalities that a doctor can manage to combat an existing covid-19 infection – rather, a preventive measure, as study data from the University of Maryland School of Medicine show. Help people avoid the worst coronavirus consequences.
Discovery: Daily, low doses of aspirin showed a lower risk of death from coronavirus and other serious complications.
More specifically, this study is intended to show that patients taking aspirin daily are about 50% less likely to die from severe COVID-19 in hospital, and are also less likely to be brought to the ICU and placed on a ventilator. The study, published Thursday in the journal, said Anesthesia and analgesia, Provides “cautious optimism” for “cheap, accessible medicine with a well-known safety profile that can help prevent serious complications.”
“These are crucial findings that need to be confirmed by a randomized clinical trial,” said Jonathan Ch Chow, MD, president and assistant professor of anesthesiology at the University of Maryland School of Medicine Medicine. “If our findings are confirmed, it would make aspirin the first widely available, over-the-counter drug to reduce mortality in COVID-19 patients.”
In terms of methodology for the study, Dr. Chow and his team looked at the medical records of 12 coronavirus patients with an average age of 55 years. They were hospitalized in the last few months due to complications of Covid-1 complications, and about 25% of patients took low doses of aspirin (mill1 mg) either before or after admission.
From the study: “Researchers found that aspirin use was associated with a 44% reduction in the risk of being placed on a mechanical ventilator, a 43% reduction in the risk of ICU admission and – most importantly – a 47% reduction in risk compared to those who did not take aspirin in hospital. There was no significant increase in adverse events, such as major bleeding, when patients in the aspirin group were hospitalized. ”
While daily aspirin use can increase the risk of something like a major bleeding or peptic ulcer disease, doctors always recommend a small daily dose of aspirin to prevent future clots when someone has a heart attack or stroke due to a blood clot.
Andy is a journalist in Memphis who also contributes to outlets such as Fast Company and The Guardian. While he doesn’t write about the technol writing g, he can be found defensively hunting down his bouncy collection of vinyl, as well as nursing his voivianism and biking on various TV shows that you might not like.
.
